GPT Healthcare Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

GPT Healthcare at Rs 152.21 is a pharma and healthcare company whose share price target of Rs 160 for 2027 represents approximately 5 percent upside from the current market price. The GPT Healthcare share price target rises to Rs 189 by 2028 and Rs 265 by 2030, implying a 4-year upside of approximately 74 percent from August 2026 levels. FY26 EPS of ₹5.2 growing approximately18% a year, capitalised at approximately26x forward earnings; growth tapers to approximately14% further out..

The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the GPT Healthcare share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.

Click Here – Get Free Investment Predictions

GPT Healthcare Company Overview

Metric	Details
NSE Ticker	GPTHEALTH
Sector	Pharma and Healthcare
CMP (07 Aug 2026)	Rs 152.21
Market Cap	Rs 1247 Cr
FY26 EPS	Rs 5.2 (18% annual growth)
GPT Healthcare Share Price Target 2027	Rs 160 (+5%)
GPT Healthcare Share Price Target 2028	Rs 189 (+24%)
GPT Healthcare Share Price Target 2030	Rs 265 (+74%)
Bull Case 2030	Rs 339
Bear Case 2030	Rs 199

What most investors miss: Regional Eastern India hospital chain (ILS Hospitals brand); 102% reported 3yr profit CAGR reflects low base/recovery from COVID-era, not sustainable run-rate

FY26 EPS of ₹5. 2 growing approximately18% a year, capitalised at approximately26x forward earnings; growth tapers to approximately14% further out. The share price target of Rs 160 for 2027 and Rs 265 for 2030 reflect this earnings trajectory.

Why Is the GPT Healthcare Share Price Target Set at Rs 160 for 2027

Domestic Branded Formulations Revenue Growth

This is the primary driver of the GPT Healthcare share price target for 2027 and 2030. FY26 EPS of ₹5.2 growing approximately18% a year, capitalised at approximately26x forward earnings; growth tapers to approximately14% further out.. Investors tracking this metric quarterly will have the earliest signal of whether the GPT Healthcare share price target timeline is on track.

Export Markets and Regulatory Compliance Track Record

The GPT Healthcare share price target of Rs 160 for 2027, rising to Rs 265 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the GPT Healthcare share price target thesis.

Product Pipeline and New Launch Capability

This structural factor underpins the long-term GPT Healthcare share price target of Rs 265 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.

Manufacturing Scale and Cost Efficiency

For the GPT Healthcare share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 189 target in 2028 when earnings quality is most clearly visible.

India's Healthcare Spending Growth Is a Structural Tailwind

India's long-term economic growth trajectory creates a secular tailwind for GPT Healthcare's business that amplifies the company-specific earnings compounding embedded in the GPT Healthcare share price target 2030 of Rs 265 (+74% from CMP Rs 152.21).

GPT Healthcare Share Price Targets 2027, 2028 and 2030

GPT Healthcare Share Price Target 2027: Rs 160

The GPT Healthcare share price target 2027 is Rs 160, representing approximately 5 percent upside from CMP Rs 152.21. FY26 EPS of ₹5.2 growing approximately18% a year, capitalised at approximately26x forward earnings; growth tapers to approximately14% further out.. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the GPT Healthcare share price target.

GPT Healthcare Share Price Target 2028: Rs 189

The GPT Healthcare share price target 2028 is Rs 189, implying approximately 24 percent upside from CMP. By FY29, GPT Healthcare should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the GPT Healthcare share price target thesis typically triggers institutional re-rating toward the Rs 189 level.

GPT Healthcare Share Price Target 2030: Rs 265

The GPT Healthcare share price target 2030 is Rs 265, implying approximately 74 percent upside from CMP and a 4-year CAGR of approximately 15 percent. By FY31, GPT Healthcare should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.

Bull Case and Bear Case for GPT Healthcare Share Price Target 2030

Bull Case: Rs 339

The bull case GPT Healthcare share price target of Rs 339 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.

Bear Case: Rs 199

The bear case GPT Healthcare share price target of Rs 199 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.

Scenario	Target 2030	Return
Bull Case	Rs 339	+123%
Base Case	Rs 265	+74%
Bear Case	Rs 199	+31%

Key Risks to the GPT Healthcare Share Price Target

USFDA Compliance and Inspection Risk

Any regulatory action on GPT Healthcare's manufacturing facilities could delay product launches and reduce the GPT Healthcare share price target earnings.

Currency Risk on Export Revenue

INR appreciation against USD and EUR reduces the INR value of GPT Healthcare's international revenues and the GPT Healthcare share price target EPS.

Generic Pricing Pressure in Export Markets

Intensifying competition in US and European generic markets compresses pricing and the GPT Healthcare share price target margin assumptions.

Clinical and Approval Timeline Risk

Delays in pipeline product approvals would push revenue ramp-up beyond the GPT Healthcare share price target timeline.

How to Invest in GPT Healthcare

Use the Univest Screener to track GPT Healthcare's quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker GPTHEALTH. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the GPT Healthcare share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.

Use the Univest Screener to Track This Stock Live

Conclusion

The GPT Healthcare share price target of Rs 160 for 2027, Rs 189 for 2028, and Rs 265 for 2030 reflects analyst consensus earnings compounding in the pharma and healthcare sector. The 4-year upside of approximately 74 percent from CMP Rs 152.21 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.

Download the Univest iOS App or Univest Android App to track GPT Healthcare share price live and get daily stock recommendations.

Frequently Asked Questions on GPT Healthcare Share Price Target 2027 2028 and 2030

What is the GPT Healthcare share price target for 2027?

Ans. The GPT Healthcare share price target for 2027 is Rs 160, representing approximately 5 percent upside from CMP Rs 152.21 as of August 2026. Please verify all data at NSE India before investing.

What is the GPT Healthcare share price target for 2030?

Ans. The GPT Healthcare share price target for 2030 is Rs 265, implying approximately 74 percent upside from CMP Rs 152.21. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.

What is the GPT Healthcare share price target for 2028?

Ans. The GPT Healthcare share price target for 2028 is Rs 189, implying approximately 24 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.

Is GPT Healthcare a good long-term investment?

Ans. GPT Healthcare has a defined analyst projection for earnings compounding through FY31 in the pharma and healthcare sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.

What are the key risks to the GPT Healthcare share price target?

Ans. Key risks include sector-specific headwinds such as usfda compliance and inspection risk, currency risk on export revenue, and broader macro slowdowns. Please review the full risks section in this article before investing.

What is the bull case for GPT Healthcare share price by 2030?

Ans. The bull case GPT Healthcare share price target for 2030 is Rs 339, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.

What is GPT Healthcare's current market cap?

Ans. GPT Healthcare has a market cap of approximately Rs 1247 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.

How can I invest in GPT Healthcare?

Ans. You can buy GPT Healthcare shares through any SEBI-registered broker by searching for NSE ticker GPTHEALTH. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.